Nektar Therapeutics (NKTR) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

NEKTAR® 38th Annual J.P. Morgan Healthcare Conference Howard Robin President & CEO January 13, 2020 2 This presentation includes forward-looking statements regarding Nektar's proprietary drug candidates, the timing of the start and conclusion of ongoing or planned clinical trials, the timing and outcome of regulatory decisions, and future availability of clinical trial data. Actual results could differ materially and these statements are subject to important risks detailed in Nektar's filings with the SEC i ...